Use of 5-hydroxytryptamine-antagonists in the treatment of mental disorders originating in childhood
申请人:GLAXO GROUP LIMITED
公开号:EP0450757A2
公开(公告)日:1991-10-09
The invention relates to the use of a compound which acts as an antagonist of 5-HT at 5-HT₃ receptors in the treatment of autism or another disorder originating in childhood in which there is mental retardation.
本发明涉及一种在 5-HT₃ 受体上作为 5-HT 拮抗剂的化合物在治疗自闭症或另一种源于儿童期的精神发育迟滞疾病中的应用。